These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10856132)

  • 1. [Recommendations from MENSURA for selection of antimicrobial agents for susceptibility testing and criteria for the interpretation of antibiograms].
    Rev Esp Quimioter; 2000 Mar; 13(1):73-86. PubMed ID: 10856132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Consensus on antimicrobial sensitivity tests in gram-positive cocci. Subcommittee on Antimicrobials, SADEBAC (Argentinian Society of Clinical Bacteriology), Argentinian Association of Microbiology].
    Famiglietti A; Quinteros M; Predari SC; Corso A; Lopardo H; Casellas JM; Bantar C; Couto E; Galas M; Goldberg M; Gutkind G; Kovensky Pupko J; Marín M; Nicola F; Pasterán F; Radice M; Soloaga R
    Rev Argent Microbiol; 2003; 35(1):29-40. PubMed ID: 12833678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Consensus for antimicrobial susceptibility testing for Enterobacteriaceae. Subcommittee on Antimicrobials, SADEBAC (Argentinian Society of Clinical Bacteriology), Argentinian Association of Microbiology].
    Famiglietti A; Quinteros M; Vázquez M; Marín M; Nicola F; Radice M; Galas M; Pasterán F; Bantar C; Casellas JM; Kovensky Pupko J; Couto E; Goldberg M; Lopardo H; Gutkind G; Soloaga R;
    Rev Argent Microbiol; 2005; 37(1):57-66. PubMed ID: 15991480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations for selecting antimicrobial agents for in vitro susceptibility studies using automatic and semiautomatic systems].
    Cantón R; Alós JI; Baquero F; Calvo J; Campos J; Castillo J; Cercenado E; Domínguez MA; Liñares J; López-Cerezo L; Marco F; Mirelis B; Morosini MI; Navarro F; Oliver A; Pérez-Trallero E; Torres C; Martínez-Martínez L;
    Enferm Infecc Microbiol Clin; 2007; 25(6):394-400. PubMed ID: 17583653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility testing in Sweden. II. Species-related zone diameter breakpoints to avoid interpretive errors and guard against unrecognized evolution of resistance.
    Ringertz S; Olsson-Liljequist B; Kahlmeter G; Kronvall G
    Scand J Infect Dis Suppl; 1997; 105():8-12. PubMed ID: 9435026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antimicrobial susceptibility testing in clinically relevant non-fermenting gram-negative bacilli: recommendations from the Antimicrobial Agents Subcommittee of the Sociedad Argentina de Bacteriología, Micología y Parasitología Clínicas, Asociación Argentina de Microbiología].
    Radice M; Marín M; Giovanakis M; Vay C; Almuzara M; Limansky A; Casellas JM; Famiglietti A; Quinteros M; Bantar C; Galas M; Kovensky Pupko J; Nicola F; Pasterán F; Soloaga R; Gutkind G
    Rev Argent Microbiol; 2011; 43(2):136-53. PubMed ID: 21731977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BSAC standardized disc susceptibility testing method (version 7).
    Andrews JM;
    J Antimicrob Chemother; 2008 Aug; 62(2):256-78. PubMed ID: 18474513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].
    Gudiol F; Aguado JM; Pascual A; Pujol M; Almirante B; Miró JM; Cercenado E; Domínguez Mde L; Soriano A; Rodríguez-Baño J; Vallés J; Palomar M; Tornos P; Bouza E;
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):105-15. PubMed ID: 19254641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we reevaluate antibiotic breakpoints?
    Ferraro MJ
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S227-9. PubMed ID: 11524723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [First Argentine consensus guidelines for in vitro antimicrobial susceptibility testing of clinically relevant anaerobic bacteria in humans/ Anaerobic Subcommittee of the Asociación Argentina de Microbiología].
    Legaria MC; Bianchini HM; Castello L; Carloni G; Di Martino A; Fernández Canigia L; Litterio M; Rollet R; Rossetti A; Predari SC
    Rev Argent Microbiol; 2011; 43(1):51-66. PubMed ID: 21491069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of moxifloxacin anaerobic susceptibility breakpoints according to the Clinical and Laboratory Standards Institute guidelines.
    Ambler J; Rennie R; Poupard J; Koeth L; Stass H; Endermann R; Choudhri S
    Diagn Microbiol Infect Dis; 2008 May; 61(1):49-57. PubMed ID: 18342475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BSAC standardized disc susceptibility testing method (version 10).
    Andrews JM; Howe RA;
    J Antimicrob Chemother; 2011 Dec; 66(12):2726-57. PubMed ID: 21921076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MENSURA-II and MENSURA-III: meetings of the Mesa Española de Normalización de la Susceptibilidad y Resistencia a Antibióticos].
    Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):571-2. PubMed ID: 1489812
    [No Abstract]   [Full Text] [Related]  

  • 14. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
    Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimicrobial susceptibility testing of bacteria isolated from animals: methods for in-vitro susceptibility testing and their suitability with regard to the generation of the most useful data for therapeutic applications].
    Schwarz S; Böttner A; Hafez HM; Kehrenberg C; Kietzmann M; Klarmann D; Klein G; Krabisch P; Kühn T; Luhofer G; Richter A; Traeder W; Waldmann KH; Wallmann J; Werckenthin C
    Berl Munch Tierarztl Wochenschr; 2003; 116(9-10):353-61. PubMed ID: 14526464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use outside the hospital of 3d generation cephalosporins. Expert Group of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].
    Enferm Infecc Microbiol Clin; 1990 Jan; 8(1):1-6. PubMed ID: 2095898
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European standards for antibiotic susceptibility testing: towards a theoretical consensus.
    Baquero F
    Eur J Clin Microbiol Infect Dis; 1990 Jul; 9(7):492-5. PubMed ID: 2226478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility testing for mycobacteria.
    Woods GL
    Clin Infect Dis; 2000 Nov; 31(5):1209-15. PubMed ID: 11073754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro activity of levofloxacin against Escherichia coli strains in acute pyelonephritis, in France in 2005].
    Soussy CJ; Lascols C; Dib-Smahi C;
    Med Mal Infect; 2007 Nov; 37(11):773-5. PubMed ID: 17936533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.